The Evolution of Model-informed Precision Dosing through Co-developed Companion Tools
Co-developing Model-informed Precision Dosing companion tools accelerates generating the evidence needed to broadly implement MIPD in the clinic.
Author: Thomas Polasek
Virtual Twin テクノロジーは、モデルを活かした精密投与のサポートに有効か？
Understand the role that Virtual Twin Technology can play in Model-Based Precision Dosing to lead to better patient outcomes.
Using Simcyp-guided ADME Biomarker Discovery to Prospectively Identify Patients at High Risk of Drug Toxicity
As novel molecular targets are being continuously discovered and new treatments developed, oncology is one of the biggest therapeutic areas in precision medicine. In particular, new targeted anti-cancer medications that are taken orally, such as the protein kinase inhibitors (KIs), are ideal candidates for model-informed precision dosing (MIPD) technologies.1 One of these technologies is called physiologically-based … Continued
個々の患者の薬物曝露量予測における Virtual Twin™ テクノロジーの活用
Physiologically-based pharmacokinetics (PBPK) is a valuable resource to support decisions throughout drug development for sponsors and regulators. PBPK is used extensively to predict drug-drug interactions (DDIs), to inform dosing and clinical study design, to predict drug exposure, to predict variation in drug clearance, and to understand mechanisms of drug disposition. Virtual Twin technology, based on … Continued
モデルを活かした精密投与におけるVirtual Twin™技術の活用
In a recent Expert Review of Clinical Pharmacology article, I assessed the status and future direction of precision dosing in clinical medicine.1 Model-informed precision dosing (MIPD) is a modeling and simulation (M&S) approach in healthcare that is used to predict the most effective and/or least toxic drug dose for a patient. MIPD could revolutionize healthcare … Continued
1 of 1
